Multimodal Postoperative Analgesia Following OSA Surgery

Bahaa Mohammed Refaie

Status: Unknown

Conditions: Obstructive Sleep Apnea

Treatments: Combination Product: Nalbuphine, ketorolac, accufuser

Study type: Interventional

Funder types: Other

Identifiers

NCT04483427

1984

Details and patient eligibility

About

Assessment of the clinical efficacy and adverse effects of multimodal analgesic regimen consisting of nalbuphine combined with ketorolac using IV continuous infusion silicon device (Accufuser) for postoperative analgesia following multilevel OSA surgeries

Enrollment: 30 estimated patients

Sex: All

Ages: 30 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• physical status of American Society of Anesthesiologists (ASA) II
• age between 30 - 50 years
• OSA patients diagnosed by polysomnography and stop-bang questionnaire
• enrolled for multilevel OSA surgery

Exclusion criteria

• history of allergy to the study drugs
• history of hepatic, cardiopulmonary or renal disease
• history of any chronic pain on medication
• history of substance abuse
• psychiatric disorder
• lack of patient cooperation.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

OSA patients after multilevel surgery

Experimental group

Treatment:

Combination Product: Nalbuphine, ketorolac, accufuser